The development of Coronavirus 3C-Like protease (3CL(pro)) inhibitors from 2010 to 2020

This review fully describes the coronavirus 3CL(pro) peptidomimetic inhibitors and nonpeptidic small molecule inhibitors developed from 2010 to 2020. Specifically, the structural characteristics, binding modes and SARs of these 3CL(pro) inhibitors are expounded in detail by division into two categor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Med Chem
Main Authors: Liu, Yuzhi, Liang, Chengyuan, Xin, Liang, Ren, Xiaodong, Tian, Lei, Ju, Xingke, Li, Han, Wang, Yongbo, Zhao, Qianqian, Liu, Hong, Cao, Wenqiang, Xie, Xiaolin, Zhang, Dezhu, Wang, Yu, Jian, Yanlin
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Masson SAS. 2020
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7409838/
https://ncbi.nlm.nih.gov/pubmed/32810751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmech.2020.112711
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados